Skip to main content
Advertisement
Advertisement
CRL
CRL logo
Charles River Laboratories International, Inc.
333.82
USD
Sponsored
+1.66
+0.50%
Nov 18, 15:58 UTC -5
Open

Charles River Laboratories International, Inc. (CRL) Earnings

CRL Earnings Reports

Positive Surprise Ratio

CRL beat 43 of 43 last estimates.

100%

Next Report

Date of Next Report
Feb 16, 2027
Estimate for Q4 26 (Revenue/ EPS)
$979.02M
/
$3.35
Implied change from Q3 26 (Revenue/ EPS)
-0.38%
/
+8.41%
Implied change from Q4 25 (Revenue/ EPS)
-1.53%
/
+40.17%

Charles River Laboratories International, Inc. earnings per share and revenue

On Nov 04, 2026, CRL reported earnings of 3.09 USD per share (EPS) for Q3 26, beating the estimate of 3.00 USD, resulting in a 2.90% surprise. Revenue reached 982.73 million, compared to an expected 968.28 million, with a 1.49% difference. The market reacted with a -7.27% price change (close before vs. close after earnings).
Looking ahead to Q4 26, -- analysts forecast an EPS of 3.35 USD, with revenue projected to reach 979.02 million USD, implying an increase of 8.41% EPS, and decrease of -0.38% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Freenome, Inc. Common stock
Report Date
Nov 10, 2026 For Q3 26
Estimate
$0.41
Actual
$0.57
Surprise
+38.69%
logo
SBC Medical Group Holdings Incorporated Common Stock
Report Date
Nov 13, 2026 For Q3 26
Estimate
$0.11
Actual
$0.15
Surprise
+32.63%
logo
Auna S.A.
Report Date
Nov 17, 2026 For Q3 26
Estimate
$0.85
Actual
$0.40
Surprise
-51.95%
logo
Park Dental Partners, Inc. Common Stock
Report Date
Nov 12, 2026 For Q3 26
Estimate
$0.30
Actual
$0.56
Surprise
+86.27%
logo
LifeMD, Inc. Common Stock
Report Date
Nov 12, 2026 For Q3 26
Estimate
-$0.14
Actual
-$0.11
Surprise
+23.77%
logo
Lifeward Ltd. Ordinary Shares
Report Date
Nov 13, 2026 For Q3 26
Estimate
-$0.83
Actual
-$1.32
Surprise
-57.82%
logo
Ainos, Inc. Common Stock
Report Date
Nov 16, 2026 For Q3 26
Estimate
-
Actual
-$0.25
Surprise
-
logo
Intelligent Bio Solutions Inc. Common Stock
Report Date
Nov 10, 2026 For Q1 27
Estimate
-$1.33
Actual
-$0.86
Surprise
+35.64%
logo
SeaStar Medical Holding Corporation Common Stock
Report Date
Nov 11, 2026 For Q3 26
Estimate
-$0.93
Actual
-$1.03
Surprise
-10.24%
logo
IceCure Medical Ltd. Ordinary Shares
Report Date
Nov 18, 2026 For Q3 26
Estimate
-$1.18
Actual
-$0.40
Surprise
+66.19%
FAQ
For Q3 2026, Charles River Laboratories International, Inc. reported EPS of $3.09, beating estimates by 2.9%, and revenue of $982.73M, 1.49% above expectations.
The stock price moved down -7.27%, changed from $351.87 before the earnings release to $326.29 the day after.
The next earning report is scheduled for Feb 16, 2027.
Based on -- analysts, Charles River Laboratories International, Inc. is expected to report EPS of $3.35 and revenue of $979.02M for Q4 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement